NCT03674411 2026-01-06Trial Evaluating MGTA-456 in Patients With High-Risk MalignancyMasonic Cancer Center, University of MinnesotaPhase 2 Active not recruiting22 enrolled 19 charts
NCT00544115 2025-06-10Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersCity of Hope Medical CenterPhase 2 Active not recruiting260 enrolled 13 charts
NCT02061800 2024-06-04CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantColumbia UniversityPhase 1/2 Active not recruiting14 enrolled
NCT03192397 2024-05-29Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantRoswell Park Cancer InstitutePhase 1/2 Active not recruiting35 enrolled